EUDA Health Holdings Limited Ordinary Shares (EUDA) is a publicly traded Healthcare sector company. As of September 29, 2026, EUDA trades at $15.63 with a market cap of $48.51M and a P/E ratio of -8.12. EUDA moved +0.00% today. Year to date, EUDA is -41.53%; over the trailing twelve months it is -30.25%. Its 52-week range spans $5.26 to $90.00. Rallies surfaces EUDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Euda Health net loss narrows to $796,950 as six-month revenue rises 13% to $3.47 million: Euda Health reported six-month revenue of $3.47 million, up 13% year over year, and a net loss of $796,950. Management flagged substantial doubt about the company’s ability to continue as a going concern, citing recurring operating losses since 2020 and a need for outside funding.
| Metric | Value |
|---|---|
| Price | $15.63 |
| Market Cap | $48.51M |
| P/E Ratio | -8.12 |
| EPS | $-2.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $90.00 |
| 52-Week Low | $5.26 |
| Volume | 5.42K |
| Avg Volume | 0 |
| Revenue (TTM) | $9.84M |
| Net Income | $-24.95M |
| Gross Margin | 34.09% |
EUDA analyst coverage data. Average price target: $0.00.